efedrina cloridrato
bioindustria laboratorio italiano medicinali s.p.a. - agonisti dei recettori alfa e beta adrenergici - agonisti dei recettori alfa e beta adrenergici
evotaz
bristol-myers squibb pharma eeig - cobicistat, atazanavir - infezioni da hiv - antivirali per uso sistemico - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 e 5.
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionato, formoterolo fumarato diidrato, glycopyrronium bromuro - malattia polmonare, ostruttiva cronica - farmaci per le malattie respiratorie ostruttive, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
bropair spiromax
teva b.v. - salmeterol xinafoate, fluticasone propionato - asma - farmaci per le malattie respiratorie ostruttive, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - asma - farmaci per le malattie respiratorie ostruttive, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
alupent
boehringer ingelheim italia s.p.a. - agonisti non selettivi dei recettori beta adrenergici - agonisti non selettivi dei recettori beta adrenergici
vems
balverda s.r.l. - agonisti selettivi dei recettori beta2-adrenergici - agonisti selettivi dei recettori beta2-adrenergici
terbasmin
pharmacia & upjohn s.p.a. - agonisti selettivi dei recettori beta2-adrenergici - agonisti selettivi dei recettori beta2-adrenergici
minipress
pfizer italiana srl - bloccanti dei recettori alfa adrenergici - bloccanti dei recettori alfa adrenergici
aminomal antiasmatico
malesci istituto farmacobiologico s.p.a. - derivati xantinici ed adrenergici - derivati xantinici ed adrenergici